HAMLET PROTEIN A/S — Credit Rating and Financial Key Figures
CVR number: 16049441
Saturnvej 51, 8700 Horsens
tel: 75631025
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 363.54 | 491.88 | 481.04 | 441.85 | 505.46 |
Other operating income | 15.60 | 21.92 | 1.56 | 0.01 | |
Costs of manufacturing | - 247.69 | - 357.11 | - 377.04 | - 386.52 | - 383.25 |
External services | -55.11 | -63.77 | -53.08 | -73.61 | -54.74 |
Gross profit | 76.34 | 92.93 | 52.48 | -18.27 | 67.47 |
Employee benefit expenses | -60.26 | -54.22 | -43.97 | -51.38 | -44.15 |
Other operating expenses | -12.80 | -0.78 | -0.11 | ||
Total depreciation | -41.91 | -23.91 | -28.34 | -23.80 | -20.68 |
EBIT | -38.63 | 14.03 | -19.94 | -93.46 | 2.64 |
Other financial income | 6.67 | 6.43 | 11.96 | 5.86 | 7.89 |
Other financial expenses | -14.51 | -22.95 | -12.82 | -21.88 | -25.65 |
Net income from associates (fin.) | 2.16 | 4.37 | 8.32 | 9.72 | 0.39 |
Pre-tax profit | -44.30 | 1.88 | -12.48 | -99.76 | -14.73 |
Income taxes | 8.75 | -0.53 | -0.64 | 11.97 | 1.01 |
Net earnings | -35.55 | 1.35 | -13.13 | -87.79 | -13.73 |
Assets (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 30.06 | 31.79 | 25.15 | 20.69 | 20.58 |
Intangible rights | 6.40 | 6.15 | 5.48 | 5.02 | 4.47 |
Goodwill | 50.80 | 43.95 | 37.10 | 30.25 | 23.40 |
Intangible assets total | 87.26 | 81.89 | 67.73 | 55.96 | 48.45 |
Land and waters | 35.51 | 32.98 | 39.93 | 36.51 | 32.92 |
Buildings | 36.80 | 38.83 | 36.80 | 32.83 | 30.29 |
Machinery and equipment | 1.48 | 0.94 | 0.36 | 0.07 | 3.11 |
Advance payments and construction in progress | 5.47 | 3.52 | 1.91 | 7.10 | 4.40 |
Tangible assets total | 79.26 | 76.27 | 79.00 | 76.51 | 70.72 |
Holdings in group member companies | 57.74 | 56.62 | 70.30 | 81.90 | 79.06 |
Other receivables | 0.13 | 0.31 | 0.13 | 0.13 | 0.13 |
Investments total | 57.87 | 56.94 | 70.43 | 82.03 | 79.18 |
Long term receivables total | |||||
Raw materials and consumables | 7.06 | 9.08 | 10.26 | 5.63 | 6.11 |
Finished products/goods | 13.45 | 20.70 | 19.14 | 28.91 | 22.82 |
Inventories total | 20.51 | 29.78 | 29.40 | 34.54 | 28.92 |
Current trade debtors | 31.03 | 38.47 | 37.85 | 35.40 | 30.56 |
Current amounts owed by group member comp. | 209.38 | 229.87 | 209.56 | 201.61 | 214.07 |
Prepayments and accrued income | 1.49 | 2.23 | 1.13 | 1.86 | 1.83 |
Current other receivables | 14.68 | 8.50 | 16.69 | 10.31 | 8.68 |
Current deferred tax assets | 4.93 | 4.40 | 2.18 | 14.15 | 15.15 |
Short term receivables total | 261.53 | 283.48 | 267.41 | 263.32 | 270.29 |
Cash and bank deposits | 3.78 | 30.76 | 6.78 | 11.60 | 0.85 |
Cash and cash equivalents | 3.78 | 30.76 | 6.78 | 11.60 | 0.85 |
Balance sheet total (assets) | 510.21 | 559.13 | 520.75 | 523.97 | 498.41 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 4.71 | 4.71 | 4.71 | 4.71 | 4.71 |
Other reserves | 19.94 | 22.00 | 36.47 | 45.10 | 40.31 |
Retained earnings | 167.51 | 124.40 | 116.65 | 97.36 | 11.12 |
Profit of the financial year | -35.55 | 1.35 | -13.13 | -87.79 | -13.73 |
Shareholders equity total | 156.60 | 152.46 | 144.70 | 59.37 | 42.41 |
Non-current loans from credit institutions | 0.85 | ||||
Non-current deferred tax liabilities | 1.99 | 5.67 | 5.01 | 5.40 | 4.92 |
Non-current liabilities total | 2.84 | 5.67 | 5.01 | 5.40 | 4.92 |
Current loans from credit institutions | 70.38 | 62.12 | 20.65 | 20.10 | 18.47 |
Current trade creditors | 34.58 | 45.89 | 68.97 | 99.27 | 97.40 |
Current owed to group member | 233.01 | 278.10 | 270.53 | 330.08 | 325.76 |
Other non-interest bearing current liabilities | 12.80 | 14.88 | 10.89 | 9.74 | 9.45 |
Current liabilities total | 350.76 | 400.99 | 371.04 | 459.19 | 451.08 |
Balance sheet total (liabilities) | 510.21 | 559.13 | 520.75 | 523.97 | 498.41 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.